Lack of effect of the novel anticonvulsant SB-204269 on voltage- dependent currents in neurones cultured from rat hippocampus

Neuroscience Letters

Volumn 271, Issue 1, 1999, Pages 57-60

  Caeser, Manfred ^a   Evans, Martyn L ^a   Benham, Christopher D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Anticonvulsants; Epilepsy; Hippocampus; Lamotrigine; SB 204269; Sodium channels

Indexed keywords

CARABERSAT; CARBAMAZEPINE; LAMOTRIGINE; SODIUM CHANNEL; SODIUM ION;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; EPILEPSY; HIPPOCAMPUS; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SODIUM CURRENT;

EID: 0033551713     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00514-5     Document Type: Article

References (12)

1. Chan W.N., Evans J.M., Hadley M.S., Herdon H.J., Jerman J.C., Morgan H.K.A., Stean T.O., Thompson M., Upton N., Vong A.K. Synthesis of novel trans-4-(substituted-benzamido)-3,4-dihydro-2H-benzo[b]pyran-3-ol derivatives as potential anticonvulsant agents with a distinctive binding profile. J. Med. Chem. 39:1996;4537-4539.
2. 3H]-SB-204269, a radiolabelled form of the anticonvulsant SB-204269, to a novel binding site in rat brain membranes. Br. J. Pharmacol. 121:1997;1687-1691.
3. Lang D.G., Wang C.M., Cooper B.R. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J. Pharmacol. Exp. Ther. 266:1993;829-835.
4. Peck A.W. Clinical pharmacology of lamotrigine. Epilepsia. 32 (Suppl. 2):1991;S9-S12.
5. + channels, expressed in a mammalian cell line, by local anesthetic, antiarrhytmic and anticonvulsant drugs. Mol. Pharmacol. 40:1991;756-765.
6. Rogawski M.A., Porter R.J. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42:1990;223-286.
7. Upton N. Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findings. Trends Pharmacol. Sci. 15:1994;456-463.
8. Upton N., Blackburn T.P., Campbell C.A., Cooper D., Evans M.L., Herdon H.J., King P.D., Ray A.M., Stean T.O., Chan W.N., Evans J.M., Thompson M. Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures. Br. J. Pharmacol. 121:1997;1679-1686.
9. Wamil A.W., Taylor C.P., McLean M.J. Effects of gabapentin on repetitive action potentials and GABA responses of mouse central neurons in cell culture. Epilepsia. 32:1991;20-21.
10. Willow M., Kuenzel E.A., Catterall W.A. Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol. Pharmacol. 25:1984;228-234.
11. White H.S. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia. 38 (Suppl. 1):1997;S9-S17.
12. + channels in rat hippocampal neurones. Pflugers Arch. 430:1995;437-446.